Frank Shafer

1.2k total citations
43 papers, 735 citations indexed

About

Frank Shafer is a scholar working on Hematology, Genetics and Immunology. According to data from OpenAlex, Frank Shafer has authored 43 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Hematology, 20 papers in Genetics and 11 papers in Immunology. Recurrent topics in Frank Shafer's work include Blood groups and transfusion (22 papers), Platelet Disorders and Treatments (11 papers) and Hemoglobinopathies and Related Disorders (11 papers). Frank Shafer is often cited by papers focused on Blood groups and transfusion (22 papers), Platelet Disorders and Treatments (11 papers) and Hemoglobinopathies and Related Disorders (11 papers). Frank Shafer collaborates with scholars based in United States, France and United Kingdom. Frank Shafer's co-authors include Guy Young, Stephanie Seremetis, Fred Lorey, Elliott Vichinsky, George C. Cunningham, Bertram H. Lubin, George Cunningham, Ilene C. Weitz, Wilma Barcellini and Alexander Röth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and The American Journal of Human Genetics.

In The Last Decade

Frank Shafer

42 papers receiving 710 citations

Peers

Frank Shafer

HEMAT

GENET

PHYSI

PPCH

IMMUN

Voravarn S. Tanphaichitr Thailand

Juri Alessandro Giannotta Italy

Khushnooma Italia India

Koichiro Ikuta Japan

Simone Cristina Olenscki Gilli Brazil

Artit Ungkanont Thailand

Joan Uehlinger United States

Małgorzata Uhrynowska Poland

Reem Ameen Kuwait

Ian Thornley Canada

Voravarn S. Tanphaichitr Thailand

Frank Shafer

560 ×1.0

HEMAT

591 ×2.3

GENET

146 ×1.2

PHYSI

172 ×1.7

PPCH

51 ×0.6

IMMUN

Citations per year, relative to Frank Shafer Frank Shafer (= 1×) peers Voravarn S. Tanphaichitr

Countries citing papers authored by Frank Shafer

Since Specialization

Citations

This map shows the geographic impact of Frank Shafer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Shafer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Shafer more than expected).

Fields of papers citing papers by Frank Shafer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Shafer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Shafer. The network helps show where Frank Shafer may publish in the future.

Co-authorship network of co-authors of Frank Shafer

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Shafer. A scholar is included among the top collaborators of Frank Shafer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Shafer. Frank Shafer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cella, David, Quentin A. Hill, Frank Shafer, et al.. (2025). FACIT-Fatigue scale in patients with cold agglutinin disease: psychometric validation and estimation of clinically meaningful change. SHILAP Revista de lepidopterología. 4. 1 indexed citations

Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2024). Sustained improvements in patient-reported outcomes after long-term sutimlimab in patients with cold agglutinin disease: results from the CADENZA study open-label extension. EClinicalMedicine. 74. 102732–102732. 1 indexed citations

Röth, Alexander, Sigbjørn Berentsen, Wilma Barcellini, et al.. (2024). Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part B. EClinicalMedicine. 74. 102733–102733. 5 indexed citations

Röth, Alexander, Catherine M. Broome, Wilma Barcellini, et al.. (2023). Long-term sutimlimab improves quality of life for patients with cold agglutinin disease: CARDINAL 2-year follow-up. Blood Advances. 7(19). 5890–5897. 8 indexed citations

Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2023). Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. American Journal of Hematology. 98(8). 1246–1253. 16 indexed citations

Röth, Alexander, Sigbjørn Berentsen, Wilma Barcellini, et al.. (2023). P1471: SUSTAINED EFFICACY OF SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IN PATIENTS WITH COLD AGGLUTININ DISEASE: RESULTS FROM PART B OF THE PHASE 3 CADENZA STUDY. HemaSphere. 7(S3). e83270db–e83270db. 1 indexed citations

Röth, Alexander, Wilma Barcellini, Tor Henrik Anderson Tvedt, et al.. (2022). Sutimlimab improves quality of life in patients with cold agglutinin disease: results of patient-reported outcomes from the CARDINAL study. Annals of Hematology. 101(10). 2169–2177. 13 indexed citations

Röth, Alexander, Wilma Barcellini, Shirley D’Sa, et al.. (2022). Complement C1s inhibition with sutimlimab results in durable response in cold agglutinin disease: CARDINAL study 1-year interim follow-up results. Haematologica. 107(7). 1698–1702. 21 indexed citations

Kosinski, Mark, et al.. (2021). Clinically Important Change in SF-12v2 Physical (PCS) and Mental (MCS) Component Summary Scores for Patients with Cold Agglutinin Disease: An Analysis Using the Phase 3 CARDINAL and CADENZA Studies. Blood. 138(Supplement 1). 2002–2002. 5 indexed citations

10.

Weitz, Ilene C., et al.. (2020). Inflammation and Fatigue in Patients with Cold Agglutinin Disease (CAD): Analysis from the Phase 3 Cardinal Study. Blood. 136(Supplement 1). 7–8. 8 indexed citations

11.

Rendo, Pablo, et al.. (2015). Nonacog alfa. Blood Coagulation & Fibrinolysis. 26(8). 912–918. 5 indexed citations

12.

Young, Guy, et al.. (2007). Single 270 μg kg⁻¹‐dose rFVIIa vs. standard 90 μg kg⁻¹‐dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison. Haemophilia. 14(2). 287–294. 123 indexed citations

13.

Tarantino, Michael D., Guy Young, Salvatore Bertolone, et al.. (2006). Single dose of anti-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. The Journal of Pediatrics. 148(4). 489–494. 77 indexed citations

14.

Gustavsson, Peter, Emanuela Garelli, Sarah E. Ball, et al.. (1998). Identification of Microdeletions Spanning the Diamond-Blackfan Anemia Locus on 19q13 and Evidence for Genetic Heterogeneity. The American Journal of Human Genetics. 63(5). 1388–1395. 57 indexed citations

15.

Hirsch, Rhoda Elison, et al.. (1997). HbC compound heterozygotes [HbC/Hb Riyadh and HbC/Hb N‐Baltimore] with opposing effects upon HbC crystallization. British Journal of Haematology. 97(2). 259–265. 9 indexed citations

16.

Matsunaga, Alison & Frank Shafer. (1996). An Acquired Inhibitor to Factor X In a Pediatric Patient with Extensive Burns. Journal of Pediatric Hematology/Oncology. 18(2). 223–226. 13 indexed citations

17.

Shafer, Frank, Catherine Schaefer, H. Ewa Witkowska, et al.. (1994). Locus-control-region-coupled betaSAntilles- and alpha2-hemoglobin genes select for high alpha2-hemoglobin expression in adult transgenic mice. Journal of Biomedical Science. 1(3). 147–153. 3 indexed citations

18.

Lorey, Fred, et al.. (1994). Universal Screening forHemoglobinopathies UsingHigh-Performance LiquidChromatography: Clinical Resultsof 2.2 Million Screens. European Journal of Human Genetics. 2(4). 262–271. 50 indexed citations

19.

Lorey, Fred, et al.. (1993). Detection of Hb E/β-Thalassemia Versus Homozygous EE Using High-Performance Liquid Chromatography Results from Newborns. Biochemical Medicine and Metabolic Biology. 49(1). 67–73. 11 indexed citations

20.

Hays, Taru, et al.. (1989). Transient erythroblastopenia of childhood. A review of 26 cases and reassessment of indications for bone marrow aspiration.. PubMed. 143(5). 605–7. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact